Developing and validating Parkinson’s Disease subtypes and their motor and cognitive progression
View / Open Files
Authors
Barker, RA
Publication Date
2018-12Journal Title
Journal of Neurology, Neurosurgery and Psychiatry
ISSN
1468-330X
Publisher
BMJ Publishing Group
Type
Article
Metadata
Show full item recordCitation
Barker, R. (2018). Developing and validating Parkinson’s Disease subtypes and their motor and cognitive progression. Journal of Neurology, Neurosurgery and Psychiatry https://doi.org/10.1136/jnnp-2018-318337
Abstract
Objectives
To use a data-driven approach to determine the existence and natural history of subtypes of Parkinson’s Disease using two large independent cohorts of patients newly diagnosed with this condition.
Methods
1,601 and 944 idiopathic PD patients, from Tracking Parkinson’s and Discovery cohorts respectively, were evaluated in motor, cognitive and non-motor domains at the baseline assessment. Patients were recently diagnosed at entry (within 3.5 years of diagnosis) and were followed-up every 18 months. We used a factor analysis followed by a k-means cluster
analysis, while prognosis was measured using random slope and intercept models.
Results
We identified four clusters: (1) fast motor progression with symmetrical motor disease, poor olfaction, cognition and postural hypotension; (2) mild motor and non-motor disease with intermediate motor progression; (3) severe motor disease, poor psychological wellbeing and poor sleep with an intermediate motor progression; (4) slow motor progression
with tremor-dominant, unilateral disease. Clusters were moderately to substantially stable across the two cohorts (kappa 0.58). Cluster 1 had the fastest motor progression in Tracking Parkinson’s at 3.2 (95% CI: 2.8-3.6) UPDRS III points per year whilst cluster 4 had the slowest at 0.6 (0.1-1.1). In Tracking Parkinson’s cluster 2 had the largest response to
levodopa 36.3% and cluster 4 the lowest 28.8%.
Conclusions
We have found four novel clusters that replicated well across two independent early PD cohorts and were associated with levodopa response and motor progression rates. This has potential implications for better understanding disease pathophysiology and the relevance of
patient stratification in future clinical trials.
Keywords
Aged, Disease Progression, Female, Humans, Levodopa, Male, Neuropsychological Tests, Parkinson Disease, Prospective Studies, Psychiatric Status Rating Scales, Severity of Illness Index
Sponsorship
The Oxford Discovery study was funded by the Monument Discovery Award from Parkinson's UK and supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford, and the NIHR Clinical Research Network: Thames Valley and South Midlands. The Tracking Parkinson's study was funded by Parkinson's UK and supported by the National Institute for Health Research (NIHR) Dendron network, the NIHR Newcastle Biomedical Research Unit based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University, and the NIHR funded Biomedical Research Centre in Cambridge.
Funder references
Medical Research Council (MR/M024962/1)
Medical Research Council (MR/L023784/1)
Identifiers
External DOI: https://doi.org/10.1136/jnnp-2018-318337
This record's URL: https://www.repository.cam.ac.uk/handle/1810/282832
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk